@misc{indiciae722994f6da66,
  title = {Naive and in vitro-activated primary mouse CD8+ T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering},
  author = {Pfenninger, P. and Yerly, L. and Abe, J.},
  year = {2021},
  doi = {10.1101/2021.09.14.460345},
  url = {https://www.biorxiv.org/content/10.1101/2021.09.14.460345v1},
  note = {Source identifier: 10.1101/2021.09.14.460345}
}